Cancer-Associated FibroblastsCarcinoma, Pancreatic DuctalCell Line, Tumor
Dr. Gregory Beatty, MD
NPI1730242363
- Publications
- 64
- Clinical trials
- 3
- Industry payments
- $78,074
- State license
- 1
- Year NPI issued
- 2006
- Practice address
- 3900 Woodland Ave, Philadelphia, PA 19104
- Practice phone
- Call (215) 615-5858
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Beatty's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Gregory Beatty is a medical oncologist in Philadelphia, Pennsylvania
Dr. Beatty practices in Philadelphia, Pennsylvania.
Dr. Beatty's NPI, 1730242363, was assigned on December 18, 2006. Dr. Beatty holds Pennsylvania license MD430283.
NPI and contact details
- NPI
- 1730242363NPI Registry (opens in a new tab)
- NPI enumeration date
- December 18, 2006
- NPI status
- Active
- Practice phone
- (215) 615-5858
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Gregory Beatty's practice address is in Philadelphia, Pennsylvania
Dr. Beatty's practice address in the NPI Registry is 3900 Woodland Ave, Philadelphia, PA 19104, in Philadelphia County. The practice phone is (215) 615-5858.
- NPI Registry address3900 Woodland Ave, Philadelphia, PA 19104 · Philadelphia CountyPhone(215) 615-5858
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Gregory Beatty's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beatty practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Beatty's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Beatty practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Gregory Beatty is one of 213 medical oncologists in Pennsylvania
Medical oncology is Dr. Beatty's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Beatty is licensed in Pennsylvania.
Specialties and state licenses
- Medical oncology, PennsylvaniaPrimary
Medical oncologists near Dr. Beatty
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Gregory Beatty has 64 publications on record
Dmand AI links 64 papers to Dr. Beatty, published from 2011 to 2024. 2019 was the busiest year, with 7. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Tumor Microenvironment. Dr. Beatty has published most often in Clin Cancer Res. Dr. Beatty's most frequent co-authors are Max Miller Wattenberg, MD, Carl June, MD and Bruce Levine, MD.
Papers64
Years published2011 to 2024
Dr. Beatty's papers by year, 2015 to 2024
Topics Dr. Beatty writes about most
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- Tumor Microenvironment
- Immunotherapy
- T-Lymphocytes
- CD40 Antigens
- Cell Line, Tumor
- Macrophages
Dr. Beatty's most frequent co-authors
- Max Miller Wattenberg, MD10 shared papers
- Carl June, MD5 shared papers
- Bruce Levine, MD5 shared papers
Recent publications by Dr. Beatty
Carcinoma, Pancreatic DuctalCD8-Positive T-LymphocytesCell Line, Tumor
Cell CommunicationGastrointestinal MicrobiomeMicrobiota
Gastroenterology
Biomarkers, TumorCarcinoma, Pancreatic DuctalCell Proliferation
Antibodies, Monoclonal, HumanizedErbB ReceptorsGlioblastoma
See who Dr. Beatty researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Beatty works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Gregory Beatty has worked on 3 clinical trials
Dmand AI links Dr. Beatty to 3 clinical trials. Conditions studied include Pancreatic Neoplasms, Rectal Diseases and Colorectal Neoplasms. Incyte Corporation sponsors the most, 2.
Clinical trials with Dr. Beatty by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Beatty's trials
- Pancreatic Neoplasms
- Rectal Diseases
- Colorectal Neoplasms
- Pancreatic Diseases
Investigators on the most trials with Dr. Beatty
- Ani Balmanoukian, MD1 shared trial
- Ignacio Garrido-Laguna, MD1 shared trial
- Thomas J. George, MD1 shared trial
Recent clinical trials with Dr. Beatty
A Phase 1b Study of INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid Tumors (opens in a new tab)
CompletedPhase 1
EpacadostatINCB050465Retifanlimab
Rectal DiseasesColorectal NeoplasmsEpacadostatPembrolizumab5-Fluorouracil
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer (opens in a new tab)
CompletedPhase 3
Pancreatic NeoplasmsPancreatic DiseasesDose- Canakinumab and Spartalizumab combined with nab-paclitaxel and gemcitabineDose -mFOLFIRINOXDose - Pamrevlumab combined with gemcitabine and nab-paclitaxel
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Gregory Beatty received $78,074 in industry payments from 2016 to 2025
CMS Open Payments shows 74 general payments to Dr. Beatty from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Incyte Corporation paid the most, $28,769. It also lists 2 research payments totaling $3,895 in 2020.
General payments to Dr. Beatty by program year, 2016 to 2025
General payments to Dr. Beatty by kind, 2016 to 2025
$78.1Kin total
- Consulting fees$62,91381%
- Speaker and faculty fees$8,73911%
- Travel and lodging$3,0874%
- Honoraria$2,0003%
- Food and beverage$1,3362%
Companies that paid Dr. Beatty the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Gregory Beatty's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Gregory Beatty
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Gregory Beatty's NPI number?
Dr. Gregory Beatty's NPI number is 1730242363. It was assigned on December 18, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Gregory Beatty?
Dr. Gregory Beatty is a medical oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Gregory Beatty practice?
Dr. Beatty practices at 3900 Woodland Ave, Philadelphia, PA 19104.
What is Dr. Gregory Beatty's office phone number?
The practice phone on file for Dr. Beatty is (215) 615-5858.
What is Dr. Gregory Beatty's medical license number?
Dr. Beatty holds Pennsylvania license MD430283.
Has Dr. Gregory Beatty received payments from drug or device companies?
CMS Open Payments shows $78,074 in general payments to Dr. Beatty from 13 companies from 2016 to 2025. The largest total came from Incyte Corporation.
How long has Dr. Gregory Beatty been practicing?
Dr. Beatty's NPI was assigned in 2006.
Does Dr. Gregory Beatty do research?
Dmand AI links 64 publications to Dr. Beatty, published from 2011 to 2024. Dr. Beatty has worked on 3 clinical trials.
Who does Dr. Gregory Beatty publish with?
Dr. Beatty's most frequent co-authors are Max Miller Wattenberg, MD (10 shared papers), Carl June, MD (5 shared papers) and Bruce Levine, MD (5 shared papers).
Selling to medical oncology practices?
See medical oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card